Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

医学 支架 内科学 心肌梗塞 佐他莫司 心脏病学 靶病变 经皮冠状动脉介入治疗 药物洗脱支架 依维莫司 血运重建 外科
作者
Sripal Bangalore,Sunil Kumar,Maria Fusaro,Nicholas Amoroso,Michael Attubato,Frederick Feit,Deepak L. Bhatt,James Slater
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:125 (23): 2873-2891 被引量:542
标识
DOI:10.1161/circulationaha.112.097014
摘要

Background— Drug-eluting stents (DES) have been in clinical use for nearly a decade; however, the relative short- and long-term efficacy and safety of DES compared with bare-metal stents (BMS) and among the DES types are less well defined. Methods and Results— PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for randomized clinical trials, until March 2012, that compared any of the Food and Drug Administration–approved durable stent and polymer DES (sirolimus-eluting stent [SES], paclitaxel-eluting stent [PES], everolimus-eluting stent [EES], zotarolimus-eluting stent [ZES], and ZES-Resolute [ZES-R]) with each other or against BMS for de novo coronary lesions, enrolling at least 100 patients and with follow-up of at least 6 months. Short-term (≤1 year) and long-term efficacy (target-vessel revascularization, target-lesion revascularization) and safety (death, myocardial infarction, stent thrombosis) outcomes were evaluated and trial-level data pooled by both mixed-treatment comparison and direct comparison analyses. From 76 randomized clinical trials with 117 762 patient-years of follow-up, compared with BMS, each DES reduced long-term target-vessel revascularization (39%–61%), but the magnitude varied by DES type (EES∼SES∼ZES-R>PES∼ZES>BMS), with a >42% probability that EES had the lowest target-vessel revascularization rate. There was no increase in the risk of any long-term safety outcomes, including stent thrombosis, with any DES (versus BMS). In addition, there was reduction in myocardial infarction (all DES except PES versus BMS) and stent thrombosis (with EES versus BMS: Rate ratio, 0.51; 95% credibility interval, 0.35–0.73). The safest DES appeared to be EES (>86% probability), with reduction in myocardial infarction and stent thrombosis compared with BMS. Short-term outcomes were similar to long-term outcomes, with SES, ZES-R, and everolimus-eluting stent being the most efficacious and EES being the safest stent. Conclusions— DES are highly efficacious at reducing the risk of target-vessel revascularization without an increase in any safety outcomes, including stent thrombosis. However, among the DES types, there were considerable differences, such that EES, SES, and ZES-R were the most efficacious and EES was the safest stent.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
2秒前
2秒前
熠熠完成签到,获得积分10
2秒前
3秒前
zxzb完成签到,获得积分10
5秒前
苹果萧完成签到 ,获得积分10
8秒前
宋江他大表哥完成签到,获得积分10
8秒前
able发布了新的文献求助10
8秒前
王先生完成签到 ,获得积分10
9秒前
H.发布了新的文献求助10
9秒前
luoluo完成签到,获得积分10
10秒前
10秒前
高分子完成签到,获得积分10
10秒前
yian发布了新的文献求助10
11秒前
yar应助体贴凌柏采纳,获得10
12秒前
自由的雪一完成签到,获得积分10
12秒前
Ava应助李振博采纳,获得200
12秒前
JW发布了新的文献求助10
13秒前
无限的千凝完成签到 ,获得积分10
14秒前
CipherSage应助YeeYee采纳,获得10
14秒前
14秒前
Ander完成签到 ,获得积分10
15秒前
化白完成签到,获得积分10
16秒前
H.完成签到,获得积分10
16秒前
chuzihang完成签到 ,获得积分10
16秒前
科研小狗完成签到,获得积分10
22秒前
11完成签到,获得积分10
23秒前
柏林寒冬应助QAQ采纳,获得10
25秒前
Flynn完成签到 ,获得积分10
27秒前
28秒前
28秒前
BZPL完成签到,获得积分10
29秒前
LANER完成签到 ,获得积分10
29秒前
29秒前
ww完成签到 ,获得积分10
29秒前
拉布拉多多不多完成签到,获得积分10
30秒前
多肉丸子完成签到,获得积分10
31秒前
yian完成签到,获得积分10
31秒前
HJJHJH发布了新的文献求助30
32秒前
正直无极完成签到,获得积分10
32秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029